- Joined
- Nov 21, 1998
- Messages
- 13,059
- Reaction score
- 7,588
The Regenerative Sportscare Institute | RSI+, New York City
RSI+ helps the body heal itself through state-of-the-art, concierge-level regenerative medicine and non-surgical orthobiologic treatment.
www.regensportscare.com
This fellowship is designed for graduates of a residency program in Physical Medicine and Rehabilitation with a strong interest in Interventional Sports and Spine Medicine with a focus on orthobiologic therapies. Qualified applicants must have a strong interest in clinical research. This fellowship is 12 months long and takes place at premier sports and spine private practice on the Upper East Side in Manhattan, New York City. Time spent in the program will be divided into approximately 60% clinical and 40% research each week. Candidates who have completed training and have been out in practice but are interested in further skill development are encouraged to apply.
Qualifications:
Successful completion of residency in Physical Medicine and Rehabilitation
Interventional musculoskeletal and or spine fellowship is preferred but not required. Candidates must feel comfortable with the basics of ultrasound diagnostics (minimum of 20 diagnostic scans required), ultrasound-guided injections (minimum of 20), and fluoroscopically guided spine injections (minimum of 100).
Clinical Goals:
o Hone skills in the clinical evaluation, diagnosis, and management of painful spine and musculoskeletal pathologies. This includes review of diagnostic imaging.
o Gain procedural skill in fluoroscopically interventional spine procedures (~20% cervical, 10% thoracic, and %70 lumbosacral) and peripheral joint and soft tissue injections (fluoroscopically and/or ultrasound guided).
Research Goals:
o Hone skills in collaborative research design, data collection, presentation, and manuscript preparation for publication.
o Research will include translational basic science topics, in addition to clinical outcomes for interventional spine, joint, and soft tissue orthobiologics.
Program start: July 1, 2021
Number of positions: 1
Length of Program: 12 months
Facility: Four fellowship trained attending physicians with academic affiliations, two procedure rooms both with ultrasound and one with brand new c-arm, MRI machine in house for each of diagnostics and research, diagnostic x-ray in house.
Program director: Greg Lutz, MD
To apply, please send your CV, a cover letter indicating reasons for interest, and two letters of recommendation commenting on research skills, clinical skill, and procedural skill to Dr. Mairin Jerome at [email protected] (please also send a text notifying of application sent with email address to 401-301-6247 to confirm receipt). Letters of reference should be emailed directly from the offices of the person writing the letter. For those still in training, one letter of recommendation must be from the program director of your current training program. Deadline to apply: February 21, 2021.
Applications will be screened and if you are selected for an interview, this will occur via zoom. A final selection will be made by March 15th.
Homepage - New Jersey Regenerative Institute
www.njregenerativeinstitute.com
New Jersey Regenerative Institute is pleased to offer a unique, non-accredited fellowship in Interventional Orthopedics and Orthobiologics. Under the direction of Dr. Gerard Malanga and in conjunction with Drs. Thomas Agesen and Jay Bowen, this 1 year fellowship will run from August 2021-August 2022, and will provide exposure to variety of sports and orthopedic conditions. The fellowship will include: sports coverage, electrodiagnosis, diagnostic and interventional ultrasound, peripheral joint and a variety of fluoroscopic spinal injections. The fellow will also be educated in the basic science and clinical application of Orthobiologics including: platelet-rich plasma, bone marrow and adipose procedures. An emphasis will be made on understanding the most current, scientifically validated measures in obtaining and delivering these tissues as well as the holistic approach to the patient both prior to and after treatment including important post-operative rehabilitation concepts.
New Jersey Regenerative Institute (NJRI) is a center of excellence with top ratings in clinical care, educational training for medical students, residents and fellows from Rutgers School of Medicine, Atlantic Sports Health and other programs across the country. NJRI is also a major research center working with the Kessler Foundation as well as a study site for several ongoing research activities with multiple publications in various journals. NJRI has had an ongoing database for several years and is an integral part of a national database registry in Orthobiologic treatments called Databiologics.
Applications will be accepted from December 2020-January 15, 2021. A select number of candidates will be called for interviews with a final selection occurring by February 2021.
All interested candidates should email Jacquie Wojak at: [email protected] for an application and other necessary items for their application.
Centeno-Schultz Interventional Fellowships
From the creators of industry-leading stem cell treatment, we provide stem cell therapy for knees, shoulders, hips, and beyond - Interventional Fellowships
centenoschultz.com
The Centeno-Schultz Clinic was the first practice in the US to use stem cells for orthopedic injuries way back in 2005 by treating joints and low back disc problems. Since then, we’ve continued to advance the art of regenerative medicine and the specialty of interventional orthopedics. We’ve made many advances in how cells are harvested, processed, and re-implanted. We’ve developed new procedural techniques and devices. As examples, we run a state of the art stem cell biology facility that includes a large clean room processing space and a separate privately funded university style research lab. This allows us to custom fit cell based therapies to our patients rather than trying to fit our patients into to what a simple automated machine could produce. As another example, rather than blindly injecting stem cells into joints and hoping that they end up in the right place, we’ve developed new interventional techniques to precisely place cells in various areas of the MSK system. For instance, we pioneered the percutaneous placement of stem cells into the ACL ligament. This technique simply didn’t exist before we realized that many of these patients could avoid surgery by accurately placing stem cells into the ligament to heal partial and full thickness tears. Another example of our innovation is in house lab research that lead to a process to dramatically increase the number of stem cells that could be isolated from bone marrow in a same day procedure.
What is Interventional Orthopedics?
We believe that due to advances in regenerative medicine, the rapid evolution in interventional cardiology that happened in the 1980-90s to today will happen in orthopedic care. In the 1980s, most major heart problems were treated with CABG. However, a quiet revolution took place that changed the status quo. Cardiologists began experimenting with percutaneous angioplasty. With every passing year from the 1980′s through the 1990′s, fewer and fewer patients needed open heart surgery and a new medical specialty was born – interventional cardiology. As time went by, more and more surgical procedures were switched to percutaneous. We believe the same thing is happening in orthopedic care with interventional orthopedics replacing more and more surgical procedures using various platelet, cytokine, and growth factor treatments as well as stem cells. We also believe that an interventional orthopedics expert needs to be able to place needle and regenerative therapeutics everywhere from the C0-C1 facet joint to the ankle TT joint or in any accessible tendon or ligament under fluoroscopic or ultrasound guidance. In summary, our fellowship is the best of an interventional spine fellowship combined with the best of a sports fellowship, but focused on the future by providing extensive experience in PRP and stem cell treatment.
Interventional Orthopedics Fellowship Overview and Qualifications
The fellowship being offered by the Centeno-Schultz Clinic (CSC) in Interventional Orthopedics and Regenerative Medicine is 12 months long, interviews typically occur in the first part of the year with the final selections made by early fall. The fellowship year will be broken up as follows:
60% Clinical Care with a focus on the use of various percutaneous stem cell and platelet technologies in regenerative medicine.
40% Research- The fellow must complete a research project under CSC supervision and submit same for publication. This includes interaction with the onsite, stem cell research lab.
Qualifications- has or seeking board certification in Physical Medicine and Rehabilitation, Anesthesiology Pain Medicine or Family Practice, Sports Medicine.
The candidate will be proficient with basic lumbar spine procedures:
At least 100 performed lumbar joint injections (facets, MBBs and SI joint) under fluoroscopy
At least 100 performed lumbar epidurals (TFs, caudals, ILs)
The candidate will be familiar with basic diagnostic ultrasound exams and have experience with needle guidance under ultrasound for basic procedures:
40 or more performed peripheral joint diagnostic ultrasound examinations (shoulder, knee, ankle, elbow, hip, etc.)
20 or more performed peripheral joint injections under ultrasound guidance (shoulder, knee, ankle, elbow, hip, etc.)
How do I Apply?
To apply, please contact Eric Speer at [email protected] and submit the following information below by June 29th, 2020:
A signed letter by your Program Director verifying the prerequisite training will be completed by the end of your residency (letter attached)
CV
A writing sample: A literature review with a maximum of one page in length. The topic is the “correlation between lumbar multifidus atrophy and axial lower back pain and radiculopathy”
A letter of recommendation from an outpatient MSK attending
We will start interviews via Skype for early candidates in June followed by in-person interviews July and August.
Last edited:
